Evidence map›Paper›PMID 36271736›Full record

ArticleMolecular microbiology2022

Mechanisms of chlorate toxicity and resistance in Pseudomonas aeruginosa.

Melanie A Spero, Jeff Jones, Brett Lomenick, Tsui-Fen Chou, Dianne K Newman

Open access · bronzeAbstract read
In one paragraph

Article in Molecular microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Hijacking anaerobic metabolism to restore antibiotic efficacy inApplied and environmental microbiology · 2025
    Article
  2. Article
  3. Targeting Anaerobic Respiration inAdvances in wound care · 2024
    Article
  4. Article
  5. Isolation and identification of chlorate-reducingMicrobiology (Reading, England) · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Melanie A SperoDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
Jeff JonesProteome Exploration Laboratory, Beckman Institute, Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
Brett LomenickProteome Exploration Laboratory, Beckman Institute, Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
Tsui-Fen ChouProteome Exploration Laboratory, Beckman Institute, Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
Dianne K NewmanDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.ORCID 0000-0003-1647-1918
California Institute of Technology · US

Funding

Purchase of a nanoLC-QTRAP Mass Spectrometer for Targeted Proteomics StudiesS10OD010788 · OD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HESS, SONJA · 2013 to 2013
$600k
Acquisition of a Q-Exactive Plus mass spectrometer.S10OD020013 · OD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HESS, SONJA · 2015 to 2015
$600k
Biological mechanisms and consequences of chlorate treatment on Pseudomonas aeruginosa chronic wound infectionsR21AI146987 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI NEWMAN, DIANNE K · 2019 to 2020
$453k
NIAID NIH HHS R21 AI146987NIH HHS S10 OD010788NIH HHS S10 OD020013
6 · The paper itself

Abstract

Pseudomonas aeruginosa is an opportunistic bacterial pathogen that often encounters hypoxic/anoxic environments within the host, which increases its tolerance to many conventional antibiotics. Toward identifying novel treatments, we explored the therapeutic potential of chlorate, a pro-drug that kills hypoxic/anoxic, antibiotic-tolerant P. aeruginosa populations. While chlorate itself is relatively nontoxic, it is enzymatically reduced to the toxic oxidizing agent, chlorite, by hypoxically induced nitrate reductase. To better assess chlorate's therapeutic potential, we investigated mechanisms of chlorate toxicity and resistance in P. aeruginosa. We used transposon mutagenesis to identify genes that alter P. aeruginosa fitness during chlorate treatment, finding that methionine sulfoxide reductases (Msr), which repair oxidized methionine residues, support survival during chlorate stress. Chlorate treatment leads to proteome-wide methionine oxidation, which is exacerbated in a ∆msrA∆msrB strain. In response to chlorate, P. aeruginosa upregulates proteins involved in a wide range of functions, including metabolism, DNA replication/repair, protein repair, transcription, and translation, and these newly synthesized proteins are particularly vulnerable to methionine oxidation. The addition of exogenous methionine partially rescues P. aeruginosa survival during chlorate treatment, suggesting that widespread methionine oxidation contributes to death. Finally, we found that mutations that decrease nitrate reductase activity are a common mechanism of chlorate resistance.

Indexed as

ChloratesProdrugsAnti-Bacterial AgentsMethionineMethionine Sulfoxide ReductasesNitrate ReductaseNitratesOxidantsProteomePseudomonas aeruginosaAnti-Bacterial AgentsChloratesMethionineMethionine Sulfoxide ReductasesNitrate ReductaseNitratesOxidantsProdrugsProteomeantibiotic tolerancechloratedrug resistancedrug toxicityPseudomonas aeruginosa

Identifiers

PMID36271736
PMCPMC9589919
OpenAlexW4292070313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.